Literature DB >> 20161091

Housing insecurity and lack of public assistance are risk factors for tuberculin skin test conversion among persons who use illicit drugs in New York City.

Sumathi Sivapalasingam1, Robert S Klein, Andrea Howard, Angie Qin, Chi-Hong Tseng, Marc N Gourevitch.   

Abstract

BACKGROUND: Persons who use illicit drugs are at increased risk of new tuberculosis (TB) infection. We conducted a prospective cohort study to assess rates and risk factors for tuberculin skin test (TST) conversion among persons with a history of illicit drug use, who were enrolled in a methadone program and had a negative baseline 2-step TST (eligible participants).
METHODS: TST and standardized interviews were administered to 401 eligible participants from 1995 through 1999, every 6 months for a 2-year follow-up time. Analyses were conducted in 2006.
RESULTS: A total of 1,447 repeat TSTs were performed during 843 person-years of follow-up (median: 2.0 years). The TST conversion rate was 3.7 per 100 person-years. In multivariate analysis, participants who converted were more likely to report ever having been homeless (HR, 2.4; 95% CI, 1.2-5.0) or ever having lived in a homeless shelter (HR, 2.4; 95% CI, 1.2-4.9) at the baseline interview, and less likely to have reported receiving public assistance since the last study visit (RR, 0.15; 95% CI, 0.07-0.32).
CONCLUSIONS: This is the first study utilizing 2-step TST at baseline to measure the incidence of TST conversion among persons who use illicit drugs. Controlling for homelessness, persons with a lack of current public assistance was identified as a risk factor for TST conversion. These individuals may most benefit from annual tuberculin skin testing.

Entities:  

Keywords:  New York City; substance use; tuberculin skin test; tuberculosis; urban

Year:  2009        PMID: 20161091      PMCID: PMC2744413          DOI: 10.1097/ADM.0b013e31819eac4c

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  22 in total

1.  Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program.

Authors:  N Salomon; D C Perlman; P Friedmann; V Ziluck; D C Des Jarlais
Journal:  Int J Tuberc Lung Dis       Date:  2000-01       Impact factor: 2.373

2.  Crack cocaine use and other risk factors for tuberculin positivity in drug users.

Authors:  Andrea A Howard; Robert S Klein; Ellie E Schoenbaum; Marc N Gourevitch
Journal:  Clin Infect Dis       Date:  2002-10-25       Impact factor: 9.079

3.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

Authors:  P A Selwyn; D Hartel; V A Lewis; E E Schoenbaum; S H Vermund; R S Klein; A T Walker; G H Friedland
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

4.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

5.  Trends in tuberculosis incidence--United States, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-03-23       Impact factor: 17.586

6.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

7.  Public health dispatch: tuberculosis outbreak in a homeless population--Portland, Maine, 2002-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-12-05       Impact factor: 17.586

8.  Tuberculosis screening in alcoholics and drug addicts.

Authors:  L N Friedman; G M Sullivan; R P Bevilaqua; R Loscos
Journal:  Am Rev Respir Dis       Date:  1987-11

9.  Drug dependence, a possible new risk factor for tuberculosis disease.

Authors:  L B Reichman; C P Felton; J R Edsall
Journal:  Arch Intern Med       Date:  1979-03

10.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.